test

Pilot Trial of KD018 with Neo-Adj Concurrent Chemo-RT in PTs with Rectal CA

Conditions

Rectum

What is the purpose of this trial?

To investigate the grade 3-4 toxicity associated with a course of neo-adjuvant chemo-radiation with concomitant Capecitabine and KD018 in patients with T3-T4 and N0-N2, M0 rectal cancer


Participation Guidelines

Age:
18 Years and older
Gender:

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale Cancer Center
Dates:
07/24/2014
Last Updated:
Study HIC#:
1404013708